当前位置: 首页 > 期刊 > 《免疫学杂志》 > 2001年第1期 > 正文
编号:10290202
中国流行株HIV-1gag和hIL-2/hIL-6核酸疫苗构建与实验免疫研究
http://www.100md.com 《免疫学杂志》2001年第1期
     作者:秦云龙 金宁一 罗坤 李凡 王宏伟 王莉馨 张永生 殷震4sh, http://www.100md.com

    单位:秦云龙 罗坤 李凡 张永生(白求恩医科大学病原生物学教研室,吉林 长春 130021);金宁一 王宏伟 王莉馨 殷震(解放军军需大学研究所病毒室,吉林 长春 130062)4sh, http://www.100md.com

    关键词:HIV-1;Gag蛋白;白细胞介素-2;白细胞介素-64sh, http://www.100md.com

    免疫学杂志010102 摘 要:目的 探讨中国流行株HIV-1gag与hIL-2/hIL-6共表达重组核酸疫苗质粒的免疫效果。方法 以核酸疫苗质粒pIRES1neo为表达载体,构建重组核酸疫苗质粒pIRES1-gag、pIRES1-gag-hIL-2、pIRES1-gag-hIL-6,通过间接免疫荧光试验、Dot-ELISA检测gag/hIL-2/hIL-6基因的表达产物。另将此重组核酸疫苗质粒免疫Balb/c小鼠,进行淋巴细胞转化试验、CD4+、CD8+T淋巴细胞数量测定、细胞毒性T淋巴细胞(CTL)特异性杀伤作用检测及血清抗体检测,结果 构建的重组质粒转染BHK细胞后可表达目的基因,免疫小鼠后可有效地刺激淋巴细胞增殖、诱导特异性CTL反应,当和hIL-2/hIL-6共表达时免疫效果更加显著。讨论 与Gag蛋白共表达的hIL-2/hIL-6能够进一步增强免疫鼠的细胞免疫与体液免疫水平,构建的重组质粒为HIV-1DNA疫苗的研究提供了一定实验基础。4sh, http://www.100md.com

    分类号:R392.7 文献标识码:A4sh, http://www.100md.com

    文章编号:1000-8861(2001)01-0005-044sh, http://www.100md.com

    Construction of DNA vaccine with HIV-1 gag and hIL-2/hIL-6 and its immunological study4sh, http://www.100md.com

    QIN Yun-long(Department of Microbiology, Norman Bethune University of Medical Sciences,Changchun 130021,China)4sh, http://www.100md.com

    JIN Ning-yi(Viral Laboratory,the Quartermaster University of PLA,Changchun 130062,China)

    LUO Kun(Department of Microbiology, Norman Bethune University of Medical Sciences,Changchun 130021,China)fe]*f, 百拇医药

    LI Fan(Department of Microbiology, Norman Bethune University of Medical Sciences,Changchun 130021,China)fe]*f, 百拇医药

    WANG Hong-wei(Viral Laboratory,the Quartermaster University of PLA,Changchun 130062,China)fe]*f, 百拇医药

    WANG Li-xin(Viral Laboratory,the Quartermaster University of PLA,Changchun 130062,China)fe]*f, 百拇医药

    ZHANG Yong-sheng(Department of Microbiology, Norman Bethune University of Medical Sciences,Changchun 130021,China)fe]*f, 百拇医药

    YIN Zhen(Viral Laboratory,the Quartermaster University of PLA,Changchun 130062,China)fe]*f, 百拇医药

    Abstract:Objective To study the immunological effects of recombinant HIV-1 DNA vaccine plasmids in mice.Methods Two DNA vaccine recombinant plasmids pIRES1-gag-hIL-2,pIRES1-gag-hIL-6 were constructed by inserting the HIV-1 gag and hIL-2/hIL-6 gene into a DNA vaccine expression vector(pIRES1neo). The expressed product of gag/hIL-2/hIL-6 gene was examined by Dot-ELISA and indirect immunofluorescent assay. Immune response of Balb/c mice immunized by the two DNA vaccine recombinant plasmids was examined by lymphocyte transformation test(LTT),cytotoxic T lymphocyte specific killer test,quantity change of T lymphocyte (CD4+, CD8+) and dynamics of specific serum IgG antibody.Results High effective expression was found in BHK cells transfected with pIRES1-gag-hIL-2,pIRES1-gag-hIL-6. Recombinant plasmids could effectively induce the proliferation of effector lymphocytes and the generation of specific lytic activity in vitro. The effects were more significant when co-expressed with human interleukins gene. Conclusion Cytokine hIL-2/hIL-6 can enhance both humoral and cellular immunity in immunized mice. Constructed recombinant plasmids might provide a basis for the development of HIV-1 DNA vaccine.

    Keywords:HIV-1;Gag protein;hIL-2/hIL-6\a, 百拇医药

    基金项目:国家自然科学基金(3977066)和国家杰出青年基金(39770661)资助项目\a, 百拇医药

    作者简介:秦云龙(1972-),男,黑龙江双鸭山市人,助教,硕士,主要从事分子病毒学的研究。Tel:(0431)7981365;E-mail:QinYL 72@263.net\a, 百拇医药

    参考文献:\a, 百拇医药

    [1]金宁一.HIV基因结构及其疫苗研究[J]. 中国病毒学, 1997,12(4):285-294.\a, 百拇医药

    [2]Hanke T, Neumann VC, Blanchard TJ, et al. Effective induction of HIV-specific CTL by multiepitope using gene gun in a combined vaccination regime [J]. Vaccine, 1999,17(6):589-596.\a, 百拇医药

    [3]Kim JJ, Tsai A, Nottingham LK,et al. Intracellular adhesion molecule-1 modulates beta-chemokines and directly co-stimulates T cells in vivo [J]. J Clin Invest, 1999,103(6):869-877.\a, 百拇医药

    [4]Ayyavoo V, Nagashunmugam T,Phung MT, et al. Construction of attenuated HIV-1 accessory gene immunization cassettes [J]. Vaccine,1999,16(19):1 872-1 879.\a, 百拇医药

    [5]Bagarazzi ML, Boyer JD, Ugen KE, et al. Safety and immunogenicity of HIV-1 DNA constructs in chimpanzees [J]. Vaccine,1998,16(19):1 836-1 841.\a, 百拇医药

    [6]Peet NM, Mckeating JA, Souza JB, et al. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAT on the immunogenicity of the envelope protein [J]. Virology,1998,251(1):59-70.\a, 百拇医药

    [7]Ugen KE, Nylanl SB, Boyer JD, et al. DNA vaccination with HIV-1 expressing constructs elicits immune responses in human [J]. Vaccine,1998,16(19):1 818-1 821.\a, 百拇医药

    [8]Winchell JM, Routray S, Betts PW, et al. Mucosal and systemic antibody responses to a C4/V3 construct following DNA vaccination of rabbits via the Peyer’s patch [J]. J Infect Dis,1998,178(3):850-853.\a, 百拇医药

    收稿日期:2000年9月20日\a, 百拇医药

    修稿日期:2000年10月25日\a, 百拇医药

    出版日期:2001年1月15日(秦云龙 金宁一 罗坤 李凡 王宏伟 王莉馨 张永生 殷震)